Roth MKM analyst Scott Searle raised the firm’s price target on Calix (CALX) to $48 from $44 and keeps a Buy rating on the shares. The company ...
Roth MKM analyst Leo Mariani lowered the firm’s price target on CNX Resources (CNX) to $28 from $30. The firm keeps a Neutral rating on the ...
Roth MKM raised the firm’s price target on TKO Group (TKO) to $185 from $148 and keeps a Buy rating on the shares. The firm remains positive on ...
O’Reilly Automotive (NASDAQ:ORLY – Get Free Report) had its price objective upped by analysts at Wells Fargo & Company from ...
Stock analysts at Wedbush decreased their Q1 2025 earnings per share (EPS) estimates for shares of Advanced Micro Devices in ...
These four Buy-rated stocks are trading under $10 and could offer patient investors enormous returns for 2025 and beyond.
The MM120 ODT Phase 3 clinical development program also includes the Voyage study for GAD and the Emerge study for major depressive disorder (MDD). The U.S. Food and Drug Administration has granted ...
BMO Capital analyst Tristan Thomas-Martin lowered the firm’s price target on Polaris (PII) to $50 from $60 and keeps a Market Perform rating on the shares. The company’s Q4 results were mostly in line ...
Roth IRA contributions can be withdrawn anytime without taxes or penalties. Converted Roth IRA funds are tax- and penalty-free after five years from Jan. 1 of the year of the conversion. Roth IRA ...